SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-060564
Filing Date
2019-11-06
Accepted
2019-11-06 17:00:06
Documents
7
Period of Report
2019-11-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921505d2_8k.htm 8-K 21243
2 EXHIBIT 3.1 tm1921505d2_ex3-1.htm EX-3.1 1302
3 EXHIBIT 99.1 tm1921505d2_ex99-1.htm EX-99.1 11344
4 GRAPHIC tm1921505d2_ex3-1img01.jpg GRAPHIC 223051
5 GRAPHIC tm1921505d2_ex3-1img02.jpg GRAPHIC 579761
6 GRAPHIC tm1921505d2_ex99-1img01.jpg GRAPHIC 18899
7 GRAPHIC tm1921505d2_ex99-1img02.jpg GRAPHIC 5355
  Complete submission text file 0001104659-19-060564.txt   1175130
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 191197080
SIC: 2834 Pharmaceutical Preparations